Conversely, if adiponectin levels are low, as seen in obesity, this could exacerbate the harmful effects of ox-LDL [72], thereby increasing Cys-C levels and heightening the risk of cardiovascular disease. This evidence concerns the gene ADIPOQ and obesity disorder.